TCL Archive Centers Eligible For Comprehensive Identification Names; Rauscher To Pick Four Now, Two More Later May 24, 1974
TCL Archive FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one. September 16, 2005
TCL Archive Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy July 26, 2013
